Navigation Links
Cynosure Announces Sale of Burlington, MA Office Building
Date:12/2/2013

WESTFORD, Mass., Dec. 2, 2013 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today announced that it has sold the former Palomar Medical Technologies headquarters, a 130,000-square-foot, three-story building at 15 Network Drive in Burlington, MA, to Network Drive Owner, LLC.  After paying transactions costs, Cynosure expects proceeds of the sale to be approximately $25.1 million. In connection with the transaction, Cynosure entered into a lease agreement with the buyer to occupy the building on a rent-free basis until June 30, 2014.  

"Our sale of the Burlington building achieves a major milestone in the integration of Palomar and our transition of all personnel to Cynosure's headquarters in Westford," said Cynosure President and CEO Michael Davin. "Our Westford campus is being expanded to accommodate the Burlington workforce, and we anticipate that will be completed by the end of the second quarter 2014.  From a financial perspective, the transaction further enhances our liquidity and capital resources."

Cynosure acquired Palomar for approximately $287 million in June 2013.

About Cynosure, Inc.
Cynosure develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, treat toe fungus and ablate sweat glands.  Cynosure's product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, and Q-switched lasers and intense pulsed light.  Cynosure sells its products globally under the Cynosure, Palomar and ConBio brand names through a direct sales force in the United States, Canada, Mexico, France, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 100 other countries.  For corporate or product information, visit Cynosure's website at www.cynosure.com.

Forward-Looking Statements
Any statements in this press release relating to the sale of Cynosure's building at 15 Network Drive in Burlington, MA and the Palomar integration and employee transition constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors including potential challenges associated with the integration of Palomar, as well as other factors discussed in Cynosure's most recent Annual Report on Form 10-K and subsequently filed Quarterly Report on Form 10-Q for the third quarter of 2013, which are filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release. Cynosure anticipates that subsequent events and developments will cause its views to change. However, although Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release.

Contact:
Scott Solomon
Vice President
Sharon Merrill
617.542.5300
CYNO@investorrelations.com


'/>"/>
SOURCE Cynosure, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cynosure Reports Third-Quarter 2013 Financial Results
2. Cynosure Completes Acquisition of Palomar Medical Technologies
3. Cynosure Added to the S&P SmallCap 600 Index
4. Cynosure to Present at UBS Global Healthcare Conference
5. Cynosure Reports First-Quarter 2013 Financial Results
6. Cynosure Announces Presentation of 16 Abstracts at 33rd ASLMS Annual Conference
7. Cynosure Reports Record Revenues for Fourth-Quarter and Full-Year 2012
8. Cynosure to Participate in Leerink Swann Global Healthcare Conference 2013
9. Cynosure to Host Fourth-Quarter 2012 Financial Results Conference Call on February 12
10. Cynosure to Present at Canaccord Genuity Medical Technology & Diagnostics Forum
11. Cynosure, Inc. Prices Public Offering of Class A Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Conference Call and Webcast to Follow Vanda Pharmaceuticals Inc. ... results for the fourth quarter of 2016 on Wednesday, February 15, ... ... PM ET on Wednesday, February 15, 2017, during which management will ... other corporate activities. To participate in the conference call, please dial ...
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin ... global anti-obesity drugs market is expected to grow at ... period and CAGR of 38.7% in the second half of the ... of 32.8% from 2016 to 2027. The market is estimated at ... in 2027. ...
(Date:1/19/2017)... 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... in the treatment of non-melanoma skin cancers and ... radiation therapy, today announced that it will report ... results on Thursday, February 2, 2017 after the market ... conference call with the investment community on Thursday, February ...
Breaking Medicine Technology:
(Date:1/21/2017)... ... ... the perfect set of tools for video editors that want to create the illusion of ... CEO of Pixel Film Studios. , Video editors using ProDOF can add realistic depth ... focus from one area into the next. ProDOF comes with 0.5 second, 1.0 second, ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Redwood Family Dermatology has recently joined their multi-specialty medical group. The dermatology ... of cosmetic services. , “We’re excited to add this excellent dermatology practice to ...
(Date:1/20/2017)... ... ... New ADA Portable Motion Trek BP 300 Lift. Built for durability, this pool lift is ... be wheeled out of the way and stored when not in use. It is freestanding ... feedback from customers into specific enhancements and created a new product that is built directly ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... International ... of nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in ... bodybuilder and nutritional scientist who was determined to create a line of products that ...
Breaking Medicine News(10 mins):